Breast cancer immunotherapy: Realities and advances

Breast cancer is the most common malignant tumor and the main cause of death in women worldwide. With increased knowledge regarding tumor escape mechanisms and advances in immunology, many new antitumor strategies make immunotherapy a promising approach for the treatment of this disease.

Read More...

Toxicity Evaluation of ConvitVax

ConvitVax is a personalized vaccine for the treatment of breast cancer, composed of autologous tumor cells, bacillus Calmette-Guérin (BCG) and low concentrations of formalin…

Read More...